Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Vaxil Bio Ltd.
  6. Company
    VXL   CA92243L1076

VAXIL BIO LTD.

(VXL)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Business Summary
Vaxil Bio Ltd., formerly Emerge Resources Corp., is an immune-oncology biotechnology company. The Company is engaged in research and development of ImMucin vaccine to treat cancer. The Company develops immunotherapies, including neoantigen peptide products, and antibodies to treat cancer and infectious diseases. The Company offers VaxHit platform, which allows for identification, isolation and production of specific antigen-based immunotherapy products. The Company offers its products from VaxHit technology, which uses the signal peptide (SP) domain in selected targets as core antigens. The Company's product, ImMucin, which has received orphan drug status and designed for the treatment of multiple myeloma (MM) cancer. The Company's ImMucin is in Phase I clinical trial to treat antigen specific immunotherapies; SPmAb2 and SPmAb6 are in pre-clinical stage to treat SP specific antibodies, and MTbuVax is in pre-clinical stage to treat anti-infectives.
Managers
Name Title Age Since
Yuval Avnir, Dr. Chief Executive Officer - 2021
Gadi Levin Chairman & Chief Financial Officer 47 2021
Terry F. Plasse, Dr. Chief Medical Officer - -
Ari S. Kellen, Dr. Independent Director - 2017
Shawn Langer, Dr. Independent Director - 2017
Members of the board
Name Title Age Since
Gadi Levin Chairman & Chief Financial Officer 47 2021
Ari S. Kellen, Dr. Independent Director - 2017
Shawn Langer, Dr. Independent Director - 2017
David Goren Director - 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 136,978,973 125,328,047 91.5% 0 0.0% 91.5%
Shareholders
NameEquities%
Ari S. Kellen 6,177,183 4.52%
Shawn Langer 5,620,000 4.11%
Gadi Levin 657,200 0.48%
David Goren 466,543 0.34%
Carret Asset Management LLC 20,000 0.015%
Yuval Avnir 0 -
Brand Portfolio
In partnership withAllbrands.markets
More brands of Vaxil Bio Ltd.